Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS launches new data pilot program aimed at clinicians

Just a day after announcing three new payment proposals for 2020, CMS introduced a new pilot program for clinicians focusing on data.

Thumbnail

CMS proposal would force hospitals to post negotiated rates

CMS unleashed a slew of proposals July 29, including 2020 payment rule proposals and a requirement for hospitals to publish the payer-specific negotiated prices of healthcare services.

Thumbnail

Pfizer to combine drugs business with Mylan

Pfizer, one of the nation’s largest pharmaceutical companies, is merging its off-patent and generic drug business with Mylan, a global generic and specialty pharmaceutical company based in the Netherlands. The spinoff deal is expected to close mid-2020, pending shareholder and regulatory approvals.

White House prepping another exec order on drug prices

President Trump is reportedly working on another executive order targeting rising drug prices, according to Reuters. 

Thumbnail

Behavioral healthcare M&A pace picks up

The behavioral healthcare services space is gaining traction in the larger healthcare sector, supported by higher mergers and acquisition activity year to date.

Thumbnail

Tenet to spin off Conifer business into separate entity

Tenet Healthcare, a Dallas-based healthcare services company that operates 65 hospitals and 500 other healthcare facilities with 110,000 employees, will spin off its revenue cycle subsidiary, Conifer, into a separate entity.

Thumbnail

Ciox Health raises $30M from Merck, New Mountain

Clinical data exchange and health technology company Ciox Health has raised $30 million in equity investment in a funding round led by Merck Global Health Innovation Fund and private equity owner New Mountain Capital.

Thumbnail

Hospital use probably won’t rise due to Medicare for all

With Medicare for all on the lips of many Democratic presidential candidates and public support for universal healthcare coverage at its highest ever, concerns about healthcare usage under such a system have arisen. However, hospital use isn’t likely to rise under a Medicare-for-all plan, according to research published in the Annals of Internal Medicine.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup